Gene signature predicted spread of brain metastases in HER-2–positive patients, HemOnc Today, July 10, 2012
Correlation Between Quantitative HER-2 Protein Expression and Risk for Brain Metastases in HER-2+ Advanced Breast Cancer Patients Receiving Trastuzumab-Containing Therapy. The oncologist 2012 Jan 10; 17(1):26-35
Praca naszych lekarzy nagrodzona podczas największego kongresu onkologicznego na świecie, Military Institute of Medicine, 25.07.2008